BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelaeof Helicobacter pylori gastritis. Lancet. 1995;345:1525-1528. [PMID: 7791437 DOI: 10.1016/s0140-6736(95)91084-0] [Cited by in Crossref: 494] [Cited by in F6Publishing: 496] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka I, Ono S, Watanabe Y, Yamamoto H, Oikawa R, Matsumoto S, Kubo M, Nishimura Y, Shimoda Y, Ono M, Yamamoto K, Sakamoto N. Long-term changes in aberrant DNA methylation and gastritis after Helicobacter pylori eradication focused on metachronous gastric cancer. Helicobacter 2022;:e12915. [PMID: 35939560 DOI: 10.1111/hel.12915] [Reference Citation Analysis]
2 Oster P, Vaillant L, Mcmillan B, Velin D. The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection. Front Immunol 2022;13:899161. [DOI: 10.3389/fimmu.2022.899161] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Dilaghi E, Lahner E, Annibale B, Esposito G. Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.03.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lam SY, Mommersteeg MC, Yu B, Broer L, Spaander MCW, Frost F, Weiss S, Völzke H, Lerch MM, Schöttker B, Zhang Y, Stocker H, Brenner H, Levy D, Hwang SJ, Wood AC, Rich SS, Rotter JI, Taylor KD, Tracy RP, Kabagambe EK, Leja M, Klovins J, Peculis R, Rudzite D, Nikitina-Zake L, Skenders G, Rovite V, Uitterlinden A, Kuipers EJ, Fuhler GM, Homuth G, Peppelenbosch MP. Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti-Helicobacter pylori IgG Titers. Gastroenterology 2022;162:1705-15. [PMID: 35031300 DOI: 10.1053/j.gastro.2022.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Di Mario F, Crafa P, Barchi A, Franzoni L, Franceschi M, Russo M, Bricca L, Brozzi L, Rodriguez Castro K, Rugge M. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter 2022;:e12872. [PMID: 34997989 DOI: 10.1111/hel.12872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kim HJ, Kim N, Park JH, Choi S, Shin CM, Lee OJ. Helicobacter pylori Eradication Induced Constant Decrease in Interleukin- 1B Expression over More Than 5 Years in Patients with Gastric Cancer and Dysplasia. Gut Liver 2020;14:735-45. [PMID: 32703913 DOI: 10.5009/gnl19312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One 2021;16:e0255601. [PMID: 34379655 DOI: 10.1371/journal.pone.0255601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Cho JH, Jeon SR, Jin SY, Park S. Standard vs magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori infection and gastric precancerous conditions. World J Gastroenterol 2021; 27(18): 2238-2250 [PMID: 34025076 DOI: 10.3748/wjg.v27.i18.2238] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Virili C, Brusca N, Capriello S, Centanni M. Levothyroxine Therapy in Gastric Malabsorptive Disorders. Front Endocrinol (Lausanne) 2020;11:621616. [PMID: 33584549 DOI: 10.3389/fendo.2020.621616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shi D, Liu L, Li H, Pan D, Yao X, Xiao W, Yao X, Yu Y. Identifying the molecular basis of Jinhong tablets against chronic superficial gastritis via chemical profile identification and symptom-guided network pharmacology analysis. Journal of Pharmaceutical Analysis 2021. [DOI: 10.1016/j.jpha.2021.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Muhsen K, Sow SO, Tapia MD, Haidara FC, Reymann M, Asato V, Chen WH, Pasetti MF, Levine MM. Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults. Sci Rep 2020;10:16871. [PMID: 33037244 DOI: 10.1038/s41598-020-71754-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ohno H, Satoh-Takayama N. Stomach microbiota, Helicobacter pylori, and group 2 innate lymphoid cells. Exp Mol Med 2020;52:1377-82. [PMID: 32908209 DOI: 10.1038/s12276-020-00485-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
13 Saxena A, Mukhopadhyay AK, Nandi SP. Helicobacter pylori: Perturbation and restoration of gut microbiome. J Biosci 2020;45. [DOI: 10.1007/s12038-020-00078-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jansen M, Banks M. Early detection and risk stratification of gastric cancer are likely to be refined with biopsies targeted through high-resolution-enhanced imaging. Gut 2020;69:1. [PMID: 31611299 DOI: 10.1136/gutjnl-2019-319921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Usui G, Shinozaki T, Jinno T, Fujibayashi K, Morikawa T, Gunji T, Matsuhashi N. Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett's esophagus: time-dependent Cox proportional-hazards analysis. BMC Gastroenterol 2020;20:270. [PMID: 32799812 DOI: 10.1186/s12876-020-01418-5] [Reference Citation Analysis]
16 Cho JH, Jeon SR, Jin SY. Clinical applicability of gastroscopy with narrow-band imaging for the diagnosis of Helicobacter pylori gastritis, precancerous gastric lesion, and neoplasia. World J Clin Cases 2020; 8(14): 2902-2916 [PMID: 32775373 DOI: 10.12998/wjcc.v8.i14.2902] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Adachi K, Kishi K, Notsu T, Mishiro T, Sota K, Ishimura N, Ishihara S. Serum Anti-Helicobacter pylori IgG Antibody Titer in H. pylori-negative Cases with a Different Gastric Mucosal Atrophy Status. Intern Med 2020;59:2817-23. [PMID: 32713919 DOI: 10.2169/internalmedicine.5132-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kpoghomou MA, Wang J, Wang T, Jin G. Association of Helicobacter pylori babA2 gene and gastric cancer risk: a meta-analysis. BMC Cancer 2020;20:465. [PMID: 32448131 DOI: 10.1186/s12885-020-06962-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kachuei V, Talebi Bezmin Abadi A, Rahimi F, Forootan M. Colonization by Pseudomonas aeruginosa and Staphylococcus aureus of Antral Biopsy Specimens from Gastritis Patients Uninfected with Helicobacter Pylori. Infect Drug Resist 2020;13:1411-7. [PMID: 32494172 DOI: 10.2147/IDR.S254967] [Reference Citation Analysis]
20 Edmond MP, Mostafa NM, El-Shazly M, Singab ANB. Two clerodane diterpenes isolated from Polyalthia longifolia leaves: comparative structural features, anti-histaminic and anti-Helicobacter pylori activities. Nat Prod Res 2021;35:5282-6. [PMID: 32363939 DOI: 10.1080/14786419.2020.1753048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ogasawara K, Nakajima S, Sato H, Sasaki T. Helicobacter pylori Eradication Using Laser Endoscope and Methylene Blue. Laser Ther 2020;29:19-27. [PMID: 32904076 DOI: 10.5978/islsm.20-OR-02] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Muhsen K, Na'amnih W, Adler A, Carmeli Y, Cohen D. Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study. Helicobacter 2020;25:e12668. [PMID: 31721371 DOI: 10.1111/hel.12668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Trieu JA, Bilal M, Saraireh H, Wang AY. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA. Dig Dis Sci. 2019;64:1079-1088. [PMID: 30771043 DOI: 10.1007/s10620-019-05526-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
24 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
25 Shah SC, Nakata C, Polydorides AD, Peek RM, Itzkowitz SH. Upper Endoscopy up to 3 Years Prior to a Diagnosis of Gastric Cancer Is Associated With Lower Stage of Disease in a USA Multiethnic Urban Population, a Retrospective Study. J Prev Med Public Health 2019;52:179-87. [PMID: 31163953 DOI: 10.3961/jpmph.18.262] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2019;9:6099. [PMID: 30988344 DOI: 10.1038/s41598-019-42365-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
27 Nolen LD, Bruden D, Miernyk K, McMahon BJ, Sacco F, Varner W, Mezzetti T, Hurlburt D, Tiesinga J, Bruce MG. H. pylori-associated pathologic findings among Alaska native patients. Int J Circumpolar Health 2018;77:1510715. [PMID: 30157723 DOI: 10.1080/22423982.2018.1510715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
28 Nam JH, Ryu KH, Park BJ, Lee CW, Park EC. Rate and predictive factors of Helicobacter pylori recurrence: Analysis of a screening cohort. Saudi J Gastroenterol 2019;25:251-6. [PMID: 30950407 DOI: 10.4103/sjg.SJG_456_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Liu D, Mehta D, Kaur S, Kumar A, Parikh K, Chawla L, Patel S, Devi A, Saha A. Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective. J Hematol Oncol 2018;11:138. [PMID: 30545376 DOI: 10.1186/s13045-018-0682-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
30 Nakayama C, Yamamichi N, Tomida S, Takahashi Y, Kageyama-Yahara N, Sakurai K, Takeuchi C, Inada KI, Shiogama K, Nagae G, Ono S, Tsuji Y, Niimi K, Fujishiro M, Aburatani H, Tsutsumi Y, Koike K. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Cancer Sci 2018;109:3853-64. [PMID: 30289576 DOI: 10.1111/cas.13821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
31 Shah SC, Itzkowitz SH, Jandorf L. Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk. Gut Liver 2018;12:38-45. [PMID: 28873510 DOI: 10.5009/gnl17091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
32 Sung J, Kim N, Lee J, Hwang YJ, Kim HW, Chung JW, Kim JW, Lee DH. Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection. Gut Liver. 2018;12:158-164. [PMID: 28918609 DOI: 10.5009/gnl17063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
33 Yagura T, Egawa S, Okano A, Mizukoshi K. Chronic Gastritis Due to Helicobacter Pylori Associated with Increased Serum Levels of CA54/61: A Report of Three Cases. Am J Case Rep 2018;19:951-5. [PMID: 30104559 DOI: 10.12659/AJCR.909299] [Reference Citation Analysis]
34 Shichijo S, Hirata Y. Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World J Gastroenterol 2018; 24(20): 2163-2172 [PMID: 29853734 DOI: 10.3748/wjg.v24.i20.2163] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
35 Iino C, Shimoyama T, Chinda D, Arai T, Chiba D, Nakaji S, Fukuda S. Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population. Front Immunol. 2018;9:712. [PMID: 29681906 DOI: 10.3389/fimmu.2018.00712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
36 Nishikawa Y, Ikeda Y, Murakami H, Hori SI, Hino K, Sasaki C, Nishikawa M. Classification of atrophic mucosal patterns on Blue LASER Imaging for endoscopic diagnosis of Helicobacter pylori-related gastritis: A retrospective, observational study. PLoS One. 2018;13:e0193197. [PMID: 29596454 DOI: 10.1371/journal.pone.0193197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
37 El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol 2018;16:992-1002.e6. [PMID: 29559361 DOI: 10.1016/j.cgh.2018.03.013] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 25.0] [Reference Citation Analysis]
38 Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther 2018;47:494-503. [PMID: 29243850 DOI: 10.1111/apt.14471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
39 Ghasemi Basir HR, Ghobakhlou M, Akbari P, Dehghan A, Seif Rabiei MA. Correlation between the Intensity of Helicobacter pylori Colonization and Severity of Gastritis. Gastroenterol Res Pract 2017;2017:8320496. [PMID: 29317866 DOI: 10.1155/2017/8320496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard DM, Riley S, Anderson J, Griffiths H, Bhandari P, Kaye P, Veitch A. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017;66:1886-99. [PMID: 28821598 DOI: 10.1136/gutjnl-2017-314109] [Cited by in Crossref: 125] [Cited by in F6Publishing: 116] [Article Influence: 25.0] [Reference Citation Analysis]
41 Cho JH, Jeon SR, Kim HG, Jin SY, Park S. The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea. Medicine (Baltimore). 2017;96:e7603. [PMID: 28723806 DOI: 10.1097/md.0000000000007603] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
42 Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X. Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond. Int J Mol Sci. 2017;18:pii: E1699. [PMID: 28771198 DOI: 10.3390/ijms18081699] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
43 Lee JY, Park HW, Choi JY, Lee JS, Koo JE, Chung EJ, Chang HS, Choe J, Yang DH, Myung SJ, Jung HY, Yang SK, Byeon JS. Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. Gut Liver. 2016;10:902-909. [PMID: 27458180 DOI: 10.5009/gnl15340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
44 Perillo M, Becker-Weidman D, Bezuidenhout AF, Siewert B, Eisenberg RL. Infections of the Gastrointestinal Tract. Semin Roentgenol 2017;52:63-72. [PMID: 28606310 DOI: 10.1053/j.ro.2017.04.009] [Reference Citation Analysis]
45 Formichella L, Romberg L, Meyer H, Bolz C, Vieth M, Geppert M, Göttner G, Nölting C, Schepp W, Schneider A, Ulm K, Wolf P, Holster IL, Kuipers EJ, Birkner B, Soutschek E, Gerhard M. Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status. J Immunol Res 2017;2017:8394593. [PMID: 28638837 DOI: 10.1155/2017/8394593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
46 Ma J, Wu D, Hu X, Li J, Cao M, Dong W. Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis. PLoS One. 2017;12:e0176463. [PMID: 28453551 DOI: 10.1371/journal.pone.0176463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
47 Darko R, Yawson AE, Osei V, Owusu-Ansah J, Aluze-Ele S. Changing Patterns of the Prevalence of Helicobacter Pylori Among Patients at a Corporate Hospital in Ghana. Ghana Med J. 2015;49:147-153. [PMID: 26693189 DOI: 10.4314/gmj.v49i3.4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
48 Jiang JX, Liu Q, Mao XY, Zhang HH, Zhang GX, Xu SF. Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012. Springerplus 2016;5:1601. [PMID: 27652174 DOI: 10.1186/s40064-016-3185-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Shih HM, Hsu TY, Chen CY, Lin CL, Kao CH, Chen CH, Yang TY, Chen WK. Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study. PLoS One 2016;11:e0162645. [PMID: 27626940 DOI: 10.1371/journal.pone.0162645] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
50 Rong Q, Xu M, Dong Q, Zhang Y, Li Y, Ye G, Zhao L. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori. BMC Complement Altern Med 2016;16:331. [PMID: 27576439 DOI: 10.1186/s12906-016-1310-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
51 Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut 2016;65:563-74. [PMID: 25779597 DOI: 10.1136/gutjnl-2014-308588] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
52 Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol 2016; 8(2): 147-158 [PMID: 26909129 DOI: 10.4251/wjgo.v8.i2.147] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
53 Kono S, Gotoda T, Yoshida S, Oda I, Kondo H, Gatta L, Naylor G, Dixon M, Moriyasu F, Axon A. Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol 2015; 21(46): 13113-13123 [PMID: 26673849 DOI: 10.3748/wjg.v21.i46.13113] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
54 Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J. The stomach in health and disease. Gut 2015;64:1650-68. [PMID: 26342014 DOI: 10.1136/gutjnl-2014-307595] [Cited by in Crossref: 182] [Cited by in F6Publishing: 150] [Article Influence: 26.0] [Reference Citation Analysis]
55 Baek DH, Kim GH, Park DY, Lee BE, Jeon HK, Lim W, Song GA. Gastric epithelial dysplasia: characteristics and long-term follow-up results after endoscopic resection according to morphological categorization. BMC Gastroenterol 2015;15:17. [PMID: 25886985 DOI: 10.1186/s12876-015-0249-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
56 Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, Kurashina K, Mieda M, Sunada K, Yamamoto H, Togashi K, Terano A, Hiraishi H. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91:30-36. [PMID: 25632914 DOI: 10.1159/000368807] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
57 Marwaha S, Schumacher MA, Zavros Y, Eghbalnia HR. Crosstalks between cytokines and Sonic Hedgehog in Helicobacter pylori infection: a mathematical model. PLoS One 2014;9:e111338. [PMID: 25364910 DOI: 10.1371/journal.pone.0111338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
58 Park MJ, Hyun MH, Yang JP, Yoon JM, Park S. Effects of the interleukin-1β-511 C/T gene polymorphism on the risk of gastric cancer in the context of the relationship between race and H. pylori infection: a meta-analysis of 20,000 subjects. Mol Biol Rep 2015;42:119-34. [PMID: 25258120 DOI: 10.1007/s11033-014-3748-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
59 Castaño-Rodríguez N, Kaakoush NO, Mitchell HM. Pattern-recognition receptors and gastric cancer. Front Immunol 2014;5:336. [PMID: 25101079 DOI: 10.3389/fimmu.2014.00336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 56] [Article Influence: 2.1] [Reference Citation Analysis]
60 Heimesaat MM, Fischer A, Plickert R, Wiedemann T, Loddenkemper C, Göbel UB, Bereswill S, Rieder G. Helicobacter pylori induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS One. 2014;9:e100362. [PMID: 24941045 DOI: 10.1371/journal.pone.0100362] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
61 Cha JM, Won KY, Chung IK, Kim GH, Lee SY, Cho YK. Effect of pronase premedication on narrow-band imaging endoscopy in patients with precancerous conditions of stomach. Dig Dis Sci. 2014;59:2735-2741. [PMID: 24861034 DOI: 10.1007/s10620-014-3218-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Brim H, Zahaf M, Laiyemo AO, Nouraie M, Pérez-Pérez GI, Smoot DT, Lee E, Razjouyan H, Ashktorab H. Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans. BMC Cancer. 2014;14:296. [PMID: 24774100 DOI: 10.1186/1471-2407-14-296] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
63 Tsukamoto T, Tatematsu M. Role of Helicobacter pylori in Gastric Neoplasia. Curr Infect Dis Rep 2014;16:402. [PMID: 24671725 DOI: 10.1007/s11908-014-0402-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
64 Jang JY, Chun HJ. Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer. World J Gastroenterol 2014; 20(11): 2760-2764 [PMID: 24659868 DOI: 10.3748/wjg.v20.i11.2760] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
65 Muhsen K, Lagos R, Reymann MK, Graham DY, Pasetti MF, Levine MM. Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One. 2014;9:e83999. [PMID: 24454714 DOI: 10.1371/journal.pone.0083999] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
66 de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut 2014;63:191-202. [PMID: 24092861 DOI: 10.1136/gutjnl-2013-305490] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 10.8] [Reference Citation Analysis]
67 Kawamura M, Sekine H, Abe S, Shibuya D, Kato K, Masuda T. Clinical significance of white gastric crypt openings observed via magnifying endoscopy. World J Gastroenterol 2013; 19(48): 9392-9398 [PMID: 24409067 DOI: 10.3748/wjg.v19.i48.9392] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
68 Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis. 2014;209:1452-1458. [PMID: 24273182 DOI: 10.1093/infdis/jit625] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
69 Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med. 2014;29:520-528. [PMID: 24065381 DOI: 10.1007/s11606-013-2630-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
70 Chen S, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter pylori Infection Decreases with Older Age in Atrophic Gastritis. Gastroenterol Res Pract 2013;2013:494783. [PMID: 24174932 DOI: 10.1155/2013/494783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
71 Watanabe K, Nagata N, Nakashima R, Furuhata E, Shimbo T, Kobayakawa M, Sakurai T, Imbe K, Niikura R, Yokoi C, Akiyama J, Uemura N. Predictive findings for Helicobacter pylori-uninfected, -infected and -eradicated gastric mucosa: Validation study. World J Gastroenterol 2013; 19(27): 4374-4379 [PMID: 23885149 DOI: 10.3748/wjg.v19.i27.4374] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
72 Leng XM, Wei MX. Advances in development of animal models of chronic atrophic gastritis. Shijie Huaren Xiaohua Zazhi 2013; 21(20): 1901-1906 [DOI: 10.11569/wcjd.v21.i20.1901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati M, Stout N, Ward Z, Goldie SJ. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med. 2013;10:e1001451. [PMID: 23700390 DOI: 10.1371/journal.pmed.1001451] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
74 Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, Kim GH, Kim HU, Kim HY, Cho SI, Kim N. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7:303-310. [PMID: 23710311 DOI: 10.5009/gnl.2013.7.3.303] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
75 Kim TH, Han SW. Atrophic Gastritis: Reversible after Treatment? Korean J Helicobacter Up Gastrointest Res 2013;13:25. [DOI: 10.7704/kjhugr.2013.13.1.25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Lan HC, Chen TS, Li AF, Chang FY, Lin HC. Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy. BMC Gastroenterol. 2012;12:182. [PMID: 23272897 DOI: 10.1186/1471-230x-12-182] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
77 Tsukamoto T, Toyoda T, Mizoshita T, Tatematsu M. Helicobacter pylori infection and gastric carcinogenesis in rodent models. Semin Immunopathol. 2013;35:177-190. [PMID: 23111700 DOI: 10.1007/s00281-012-0357-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
78 Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136-47. [PMID: 22242613 DOI: 10.3109/00365521.2011.645501] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 8.2] [Reference Citation Analysis]
79 Sause WE, Castillo AR, Ottemann KM. The Helicobacter pylori autotransporter ImaA (HP0289) modulates the immune response and contributes to host colonization. Infect Immun. 2012;80:2286-2296. [PMID: 22566509 DOI: 10.1128/iai.00312-12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
80 Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, Campo SM, Tomao S. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol 2012; 4(3): 30-36 [PMID: 22468181 DOI: 10.4251/wjgo.v4.i3.30] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
81 Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, Yoon DH, Lim SH, Kim YS, Yim JY, Kim JS, Jung HC. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver 2011;5:321-7. [PMID: 21927661 DOI: 10.5009/gnl.2011.5.3.321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
82 Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, Yoon DH, Lim SH, Kim YS, Yim JY. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver. 2011;5:321-327. [PMID: 21927661 DOI: 10.5009/qnl.2011.5.3.321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Thrift AP, Pandeya N, Smith KJ, Green AC, Hayward NK, Webb PM, Whiteman DC. Helicobacter pylori infection and the risks of Barrett’s oesophagus: a population-based case-control study. Int J Cancer. 2012;130:2407-2416. [PMID: 21681741 DOI: 10.1002/ijc.26242] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
84 Takao T, Ishikawa T, Ando T, Takao M, Matsumoto T, Isozaki Y, Okita M, Nagao Y, Oyamada H, Yokoyama K. Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics. Gastroenterol Res Pract. 2011;2011:631461. [PMID: 21776250 DOI: 10.1155/2011/6b1461] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Takao T, Ishikawa T, Ando T, Takao M, Matsumoto T, Isozaki Y, Okita M, Nagao Y, Oyamada H, Yokoyama K. Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics. Gastroenterol Res Pract. 2011;2011:631461. [PMID: 21776250 DOI: 10.1155/2011/631461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
86 Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T. Regular arrangement of collecting venules: Does patient age affect its accuracy? World J Gastrointest Endosc 2011;3:118-23. [PMID: 21860679 DOI: 10.4253/wjge.v3.i6.118] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
87 den Hoed CM, de Vries AC, Mensink PB, Dierikx CM, Suzuki H, Capelle L, van Dekken H, Ouwendijk R, Kuipers EJ. Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial. Can J Gastroenterol 2011;25:207-13. [PMID: 21523262 DOI: 10.1155/2011/672093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
88 Sato R, Murakami K, Okimoto T, Watanabe K, Kodama M, Fujioka T. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. J Gastroenterol. 2011;46:991-997. [PMID: 21594563 DOI: 10.1007/s00535-011-0416-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
89 Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology. 2010;139:1819-1822. [PMID: 21029801 DOI: 10.1053/j.gastro.2010.10.037] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
90 Hishida A, Matsuo K, Goto Y, Hamajima N. Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol 2010; 2(10): 369-379 [PMID: 21160888 DOI: 10.4251/wjgo.v2.i10.369] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
91 Liu X, Liu NN, Wang Y, Yin PH, Wu Q, Zhou N, Sun J, Fan ZZ, Li Q. Helicobacter pylori infection increases the transcriptional activity of COX-2 promoter via the p38MAPK signal transduction pathway in MKN45 cells. Shijie Huaren Xiaohua Zazhi 2010; 18(28): 3003-3007 [DOI: 10.11569/wcjd.v18.i28.3003] [Reference Citation Analysis]
92 Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 2010;116:2941-53. [PMID: 20564399 DOI: 10.1002/cncr.25030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
93 Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol. 2010;25:439-448. [PMID: 20585973 DOI: 10.1007/s10654-010-9482-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
94 Oleastro M, Santos A, Cordeiro R, Nunes B, Mégraud F, Ménard A. Clinical relevance and diversity of two homologous genes encoding glycosyltransferases in Helicobacter pylori. J Clin Microbiol 2010;48:2885-91. [PMID: 20554820 DOI: 10.1128/JCM.00401-10] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
95 Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Zullo A. Role of interleukin polymorphisms in gastric cancer: “Pros and cons”. World J Gastrointest Oncol 2010; 2(6): 265-271 [PMID: 21160639 DOI: 10.4251/wjgo.v2.i6.265] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
96 Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010; 16(19): 2323-2330 [PMID: 20480516 DOI: 10.3748/wjg.v16.i19.2323] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 139] [Article Influence: 14.6] [Reference Citation Analysis]
97 Travis PB, Goodman KJ, O'Rourke KM, Groves FD, Sinha D, Nicholas JS, VanDerslice J, Lackland D, Mena KD. The association of drinking water quality and sewage disposal with Helicobacter pylori incidence in infants: the potential role of water-borne transmission. J Water Health 2010;8:192-203. [PMID: 20009261 DOI: 10.2166/wh.2009.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
98 Con SA, Takeuchi H, Nishioka M, Morimoto N, Sugiura T, Yasuda N, Con-Wong R. Clinical relevance of Helicobacter pylori babA2 and babA2/B in Costa Rica and Japan. World J Gastroenterol 2010; 16(4): 474-478 [PMID: 20101774 DOI: 10.3748/wjg.v16.i4.474] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
99 Veijola LI, Oksanen AM, Sipponen PI, Rautelin HIK. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol 2010; 16(1): 83-88 [PMID: 20039453 DOI: 10.3748/wjg.v16.i1.83] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
100 Park WS. Molecular Pathogenesis of Gastric Cancer. J Korean Med Assoc 2010;53:270. [DOI: 10.5124/jkma.2010.53.4.270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Urita Y, Watanabe T, Maeda T, Arita T, Sasaki Y, Ishii T, Yamamoto T, Kugahara A, Nakayama A, Nanami M. Extensive atrophic gastritis increases intraduodenal hydrogen gas. Gastroenterol Res Pract. 2008;2008:584929. [PMID: 18795142 DOI: 10.1155/2008/584929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
102 Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7:887-94. [DOI: 10.1038/nrmicro2245] [Cited by in Crossref: 504] [Cited by in F6Publishing: 492] [Article Influence: 38.8] [Reference Citation Analysis]
103 Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, Uhm MS, Park YS, Lee DH, Jung HC, Song IS. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55:1364-1375. [PMID: 19629687 DOI: 10.1007/s10620-009-0891-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
104 de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol 2009;104:1342-5. [PMID: 19491846 DOI: 10.1038/ajg.2008.15] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
105 Wiedemann T, Loell E, Mueller S, Stoeckelhuber M, Stolte M, Haas R, Rieder G. Helicobacter pylori cag-Pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PLoS One. 2009;4:e4754. [PMID: 19270747 DOI: 10.1371/journal.pone.0004754] [Cited by in Crossref: 35] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
106 Graham DY, Genta RM. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep 2008;10:543-7. [PMID: 19006608 DOI: 10.1007/s11894-008-0100-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
107 Yeh JM, Kuntz KM, Ezzati M, Goldie SJ. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer. 2009;124:157-166. [PMID: 18823009 DOI: 10.1002/ijc.23864] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
108 Wabinga H. Helicobacter pylori and histopathological changes of gastric mucosa in Uganda population with varying prevalence of stomach cancer. Afr Health Sci 2005;5:234-7. [PMID: 16245994 DOI: 10.5555/afhs.2005.5.3.234] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
109 Yang Z, Lv NH. Role of P53-MDM2 negative-feedback in the pathopoiesis of Helicobacter pyloriShijie Huaren Xiaohua Zazhi 2008; 16(20): 2274-2279 [DOI: 10.11569/wcjd.v16.i20.2274] [Reference Citation Analysis]
110 Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008;57:561-7. [PMID: 18194986 DOI: 10.1136/gut.2007.133462] [Cited by in Crossref: 158] [Cited by in F6Publishing: 144] [Article Influence: 11.3] [Reference Citation Analysis]
111 Karaman A, Binici DN, Kabalar ME, Dursun H, Kurt A. Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H pylori infection. World J Gastroenterol 2008; 14(16): 2534-2539 [PMID: 18442201 DOI: 10.3748/wjg.14.2534] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Tang X, Liu G, Wang P, Wu T; Cochrane Upper GI and Pancreatic Diseases Group. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd006985] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, Kuipers EJ. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-70. [PMID: 17698860 DOI: 10.1136/gut.2007.127167] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
114 Imagawa S, Yoshihara M, Ito M, Yoshida S, Wada Y, Tatsugami M, Takamura A, Tanaka S, Haruma K, Chayama K. Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study. Dig Dis Sci. 2008;53:1818-1823. [PMID: 17999184 DOI: 10.1007/s10620-007-0077-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
115 Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;102:1789-98. [PMID: 17521398 DOI: 10.1111/j.1572-0241.2007.01335.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
116 Clarke D, Vemuri M, Gunatilake D, Tewari S. Helicobacter pylori Infection in Five Inpatient Units for People with Intellectual Disability and Psychiatric Disorder. J Appl Res Int Dis 2007;0:070702031251002-???. [DOI: 10.1111/j.1468-3148.2007.00358.x] [Reference Citation Analysis]
117 Nouraie M, Radmard AR, Zaer-Rezaii H, Razjouyan H, Nasseri-Moghaddam S, Malekzadeh R. Hygiene could affect GERD prevalence independently: a population-based study in Tehran. Am J Gastroenterol 2007;102:1353-60. [PMID: 17437507 DOI: 10.1111/j.1572-0241.2007.01208.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
118 Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol 2007; 13(10): 1541-1546 [PMID: 17461446 DOI: 10.3748/wjg.v13.i10.1541] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
119 Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15. [PMID: 17322988 DOI: 10.1007/s00535-006-1990-z] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 7.3] [Reference Citation Analysis]
120 Di Mario F, Cavallaro LG, Moussa AM, Caruana P, Merli R, Maini A, Bertolini S, Dal Bó N, Rugge M, Cavestro GM. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci. 2006;51:1791-1795. [PMID: 17203556 DOI: 10.1007/s10620-006-9206-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
121 Dimitrov G, Gottrand F. Does gastric atrophy exist in children? World J Gastroenterol 2006; 12(39): 6274-6279 [PMID: 17072948 DOI: 10.3748/wjg.v12.i39.6274] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
122 Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD. H pylori infection among 1000 southern Iranian dyspeptic patients. World J Gastroenterol 2006; 12(34): 5479-5482 [PMID: 17006984 DOI: 10.3748/wjg.v12.i34.5479] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
123 Atsuta Y, Ito LS, Oba-Shinjo SM, Uno M, Shinjo SK, Marie SK, Goto Y, Hamajima N. Associations of TNF-A-1031TT and -857TT genotypes with Helicobacter pylori seropositivity and gastric atrophy among Japanese Brazilians. Int J Clin Oncol. 2006;11:140-145. [PMID: 16622749 DOI: 10.1007/s10147-005-0549-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
124 Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol 2006; 12(32): 5205-5210 [PMID: 16937534 DOI: 10.3748/wjg.v12.i32.5205] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
125 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]
126 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]
127 Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006;19:449-90. [DOI: 10.1128/cmr.00054-05] [Reference Citation Analysis]
128 Bhat N, Gaensbauer J, Peek RM, Bloch K, Tham KT, Blaser MJ, Perez-Perez G. Local and systemic immune and inflammatory responses to Helicobacter pylori strains. Clin Diagn Lab Immunol 2005;12:1393-400. [PMID: 16339062 DOI: 10.1128/CDLI.12.12.1393-1400.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
129 Vieth M, Stolte M. [Gastritis from a histological point of view]. Internist (Berl) 2006;47:578, 580-7. [PMID: 16612608 DOI: 10.1007/s00108-006-1618-7] [Reference Citation Analysis]
130 Kodama M, Murakami K, Sato R, Okimoto T, Nishizono A, Fujioka T. Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis. World J Gastroenterol. 2005;11:7063-7071. [PMID: 16437649 DOI: 10.3748/wjg.v11.i45.7063] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
131 Kato S, Nakajima S, Nishino Y, Ozawa K, Minoura T, Konno M, Maisawa S, Toyoda S, Yoshimura N, Vaid A, Genta RM. Association Between Gastric Atrophy and Helicobacter pylori Infection in Japanese Children: A Retrospective Multicenter Study. Dig Dis Sci 2006;51:99-104. [DOI: 10.1007/s10620-006-3091-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
132 Ali M, Khan AA, Tiwari SK, Ahmed N, Rao LV, Habibullah C. Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol 2005; 11(43): 6815-6822 [PMID: 16425389 DOI: 10.3748/wjg.v11.i43.6815] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
133 Abe H, Murakami K, Satoh S, Sato R, Kodama M, Arita T, Fujioka T. Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol. 2005;40:563-569. [PMID: 16007389 DOI: 10.1007/s00535-005-1589-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
134 Gurbuz AK, Ozel AM, Ozturk R, Yildirim S, Yazgan Y, Demirturk L. Effect of N-acetyl cysteine on Helicobacter pylori. South Med J 2005;98:1095-7. [PMID: 16351030 DOI: 10.1097/01.smj.0000182486.39913.da] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
135 Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005;54:1536-40. [PMID: 15985559 DOI: 10.1136/gut.2005.072009] [Cited by in Crossref: 227] [Cited by in F6Publishing: 222] [Article Influence: 13.4] [Reference Citation Analysis]
136 Annibale B, Lahner E, Negrini R, Baccini F, Bordi C, Monarca B, Fave GD. Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol 2005; 11(34): 5351-5357 [PMID: 16149145 DOI: 10.3748/wjg.v11.i34.5351] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
137 Lo CC, Hsu PI, Lo GH, Lai KH, Tseng HH, Lin CK, Chan HH, Tsai WL, Chen WC, Peng NJ. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005; 11(30): 4715-4720 [PMID: 16094716 DOI: 10.3748/wjg.v11.i30.4715] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
138 Salomaa-Räsänen A, Kosunen TU, Mattila J, Sarna S, Rautelin H. Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol 2004;11:1185-8. [PMID: 15539526 DOI: 10.1128/CDLI.11.6.1185-1188.2004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
139 Bergman MP, Klinkenberg-Knol EC, Faller G, Aar A, Lakhai W, Vandenbroucke-Grauls CM, Kuipers EJ, Appelmelk BJ. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production. Aliment Pharmacol Ther 2005;21:977-83. [PMID: 15813833 DOI: 10.1111/j.1365-2036.2005.02386.x] [Reference Citation Analysis]
140 Karita M, Teramukai S, Matsumoto S, Shibuta H. Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces progressive atrophic gastritis that is associated with the development of gastric cancer. Dig Dis Sci. 2005;50:56-64. [PMID: 15712638 DOI: 10.1007/s10620-005-1278-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
141 Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005;54:330-5. [PMID: 15710978 DOI: 10.1136/gut.2003.033050] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 9.5] [Reference Citation Analysis]
142 Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol 2005; 11(7): 1032-1036 [PMID: 15742409 DOI: 10.3748/wjg.v11.i7.1032] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
143 Sarker S, Nahar S, Rahman M, Bardhan P, Nair G, Beglinger C, Gyr N. High prevalence of cagA and vacA seropositivity in asymptomatic Bangladeshi children with Helicobacter pylori infection. Acta Paediatrica 2004;93:1432-6. [DOI: 10.1111/j.1651-2227.2004.tb02624.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
144 Windle HJ, Ang YS, Athie-Morales V, McManus R, Kelleher D. Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals. Gut 2005;54:25-32. [PMID: 15591500 DOI: 10.1136/gut.2003.025494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
145 Karita M, Noriyasu A, Teramukai S, Matsumoto S. Atrophic progression induced by H. pylori infection is correlated with a changing pepsinogen I value and associated with the development of gastric cancer. Dig Dis Sci 2004;49:1615-20. [PMID: 15573915 DOI: 10.1023/b:ddas.0000043374.80528.ee] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
146 Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004; 10(21): 3146-3150 [PMID: 15457561 DOI: 10.3748/wjg.v10.i21.3146] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
147 Zhang GX, Gu YH, Zhao ZQ, Xu SF, Zhang HJ, Wang HD, Hao B. Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases. World J Gastroenterol 2004; 10(12): 1759-1762 [PMID: 15188501 DOI: 10.3748/wjg.v10.i12.1759] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
148 Oliveira C, Suriano G, Ferreira P, Canedo P, Kaurah P, Mateus R, Ferreira A, Ferreira AC, Oliveira MJ, Figueiredo C, Carneiro F, Keller G, Huntsman D, Machado JC, Seruca R. Genetic screening for familial gastric cancer. Hered Cancer Clin Pract 2004;2:51-64. [PMID: 20233471 DOI: 10.1186/1897-4287-2-2-51] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
149 Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321-333. [PMID: 14755326 DOI: 10.1172/jci20925] [Cited by in Crossref: 561] [Cited by in F6Publishing: 554] [Article Influence: 31.2] [Reference Citation Analysis]
150 Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321-333. [PMID: 14755326 DOI: 10.1172/jci200420925] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
151 Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20. [PMID: 14684569 DOI: 10.1136/gut.53.1.12] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 7.9] [Reference Citation Analysis]
152 Li H, Stoicov C, Cai X, Wang TC, Houghton J. Helicobacter and gastric cancer disease mechanisms: Host response and disease susceptibility. Curr Gastroenterol Rep 2003;5:459-67. [DOI: 10.1007/s11894-003-0034-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
153 Karita M, Noriyasu A, Kosako E, Teramukai S, Matsumoto S. Relationship between pepsinogen I& amp; II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases. Dig Dis Sci. 2003;48:1839-1845. [PMID: 14561011 DOI: 10.1023/a:1025423902479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
154 van Grieken NC, Meijer GA, zur Hausen A, Meuwissen SG, Baak JP, Kuipers EJ. Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia. J Clin Pathol. 2003;56:358-361. [PMID: 12719456 DOI: 10.1136/jcp.56.5.358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
155 Franceschi F, Genta RM, Sepulveda AR. Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J Gastroenterol 2002;37 Suppl 13:17-23. [PMID: 12109660 DOI: 10.1007/BF02990094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
156 Takahashi S. Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan. J Gastroenterol. 2002;37 Suppl 13:24-27. [PMID: 12109661 DOI: 10.1007/bf02990095] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
157 Ito LS, Oba SM, Hamajima N, Marie SK, Uno M, Shinjo SK, Kino A, Lavilla F, Inoue M, Tajima K, Tominaga S. Helicobacter pylori seropositivity among 963 Japanese Brazilians according to sex, age, generation, and lifestyle factors. Jpn J Cancer Res 2001;92:1150-6. [PMID: 11714438 DOI: 10.1111/j.1349-7006.2001.tb02134.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
158 Sato Y, Iwafuchi M, Ueki J, Yoshimura A, Mochizuki T, Motoyama H, Sugimura K, Honma T, Narisawa R, Ichida T, Asakura H, Van Thiel DH. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci. 2002;47:579-585. [PMID: 11911346 DOI: 10.1023/a:1017972204219] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
159 Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. Am J Gastroenterol 2002;97:594-9. [PMID: 11922552 DOI: 10.1111/j.1572-0241.2002.05535.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
160 Gisbert JP, María Pajares J. Prevalencia de la infección por Helicobacter pylori en la enfermedad por reflujo gastroesofágico y en el esófago de Barrett: revisión sistemática y metaanálisis. Medicina Clínica 2002;119:217-23. [DOI: 10.1016/s0025-7753(02)73368-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
161 Uchida K, Okazaki K, Debrecceni A, Nishi T, Iwano H, Inai M, Uose S, Nakase H, Ohana M, Oshima C, Matsushima Y, Kawanami C, Hiai H, Masuda T, Chiba T. Analysis of cytokines in the early development of gastric secondary lymphoid follicles in Helicobacter pylori-infected BALB/c mice with neonatal thymectomy. Infect Immun 2001;69:6749-54. [PMID: 11598047 DOI: 10.1128/IAI.69.11.6749-6754.2001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
162 Mizushima T, Sugiyama T, Komatsu Y, Ishizuka J, Kato M, Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol. 2001;39:2463-2465. [PMID: 11427555 DOI: 10.1128/jcm.39.7.2463-2465.2001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
163 Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001;49:335-40. [PMID: 11511553 DOI: 10.1136/gut.49.3.335] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 3.4] [Reference Citation Analysis]
164 Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Tajima K, Tominaga S. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001;92:488-93. [PMID: 11376556 DOI: 10.1111/j.1349-7006.2001.tb01120.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
165 Tucci A, Poli L, Biasco G, Paparo GF, Tosetti C, Fusaroli P, Sambri V, Donati M, Grigioni W, Labate AM, Stanghellini V, Caletti G. Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis. Dig Dis Sci 2001;46:1573-83. [PMID: 11478512 DOI: 10.1023/a:1010668727340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
166 van Grieken NC, Weiss MM, Meijer GA, Bloemena E, Lindeman J, Offerhaus GJ, Meuwissen SG, Baak JP, Kuipers EJ. Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol. 2001;54:63-69. [PMID: 11271791 DOI: 10.1136/jcp.54.1.63] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
167 Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001;96:16-26. [PMID: 11197247 DOI: 10.1111/j.1572-0241.2001.03447.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 73] [Article Influence: 0.5] [Reference Citation Analysis]
168 Kim N, Lim SH, Lee KH, Choi SE, Jung HC, Song IS, Kim CY. Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers. Dig Dis Sci. 2000;45:1754-1762. [PMID: 11052316 DOI: 10.1023/a:1005534328511] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
169 Kikuchi S, Nakajima T, Kobayashi O, Yamazaki T, Kikuichi M, Mori K, Oura S, Watanabe H, Nagawa H, Otani R, Okamoto N, Kurosawa M, Anzai H, Kubo T, Konishi T, Futagawa S, Mizobuchi N, Kobori O, Kaise R, Sato T, Inaba Y, Wada O. Effect of age on the relationship between gastric cancer and Helicobacter pylori. Tokyo Research Group of Prevention for Gastric Cancer. Jpn J Cancer Res 2000;91:774-9. [PMID: 10965016 DOI: 10.1111/j.1349-7006.2000.tb01012.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
170 Kikuchi S, Kurosawa M, Sakiyama T, Tenjin H, Miki K, Wada O, Inaba Y. Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res. 2000;91:471-476. [PMID: 10835490 DOI: 10.1111/j.1349-7006.2000.tb00969.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
171 Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, Luckers AE, Klinkenberg-Knol EC, Festen HP, Viergever PP, Lindeman J, Meuwissen SG. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 2000;46:615-21. [PMID: 10764703 DOI: 10.1136/gut.46.5.615] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 3.7] [Reference Citation Analysis]
172 Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, Rautelin H. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000;46:460-3. [PMID: 10716672 DOI: 10.1136/gut.46.4.460] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 2.8] [Reference Citation Analysis]
173 Kuipers EJ, Israel DA, Kusters JG, Gerrits MM, Weel J, van Der Ende A, van Der Hulst RW, Wirth HP, Höök-Nikanne J, Thompson SA, Blaser MJ. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis 2000;181:273-82. [PMID: 10608776 DOI: 10.1086/315173] [Cited by in Crossref: 122] [Cited by in F6Publishing: 122] [Article Influence: 5.5] [Reference Citation Analysis]
174 Verhulst ML, van Oijen AH, Roelofs HM, Peters WH, Jansen JB. Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci 2000;45:629-32. [PMID: 10749343 DOI: 10.1023/a:1005426130826] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
175 Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000;95:114-21. [PMID: 10638568 DOI: 10.1111/j.1572-0241.2000.01609.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]
176 Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA. 1999;96:12778-12783. [PMID: 10535999 DOI: 10.1073/pnas.96.22.12778] [Cited by in Crossref: 411] [Cited by in F6Publishing: 398] [Article Influence: 17.9] [Reference Citation Analysis]
177 Trevisani L, Sartori S, Ruina M, Caselli M, Rossi MR, Costa F, Bellini M, Iaquinto G, Gardullo N, Todisco A. Helicobacter pylori stool antigen test: clinical evaluation and cost analysis of a new enzyme immunoassay. Dig Dis Sci 1999;44:2303-6. [PMID: 10573378 DOI: 10.1023/a:1026621207664] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
178 Byrne MF, Murray FE. Formulary management of proton pump inhibitors. Pharmacoeconomics 1999;16:225-46. [PMID: 10558037 DOI: 10.2165/00019053-199916030-00002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
179 Rowland M, Imrie C, Bourke B, Drumm B. How should Helicobacter pylori infected children be managed? Gut 1999;45 Suppl 1:I36-9. [PMID: 10457035 DOI: 10.1136/gut.45.2008.i36] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
180 Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, Frati L, Luzi G. Gastric pathology in patients with common variable immunodeficiency. Gut 1999;45:77-81. [PMID: 10369708 DOI: 10.1136/gut.45.1.77] [Cited by in Crossref: 91] [Cited by in F6Publishing: 67] [Article Influence: 4.0] [Reference Citation Analysis]
181 Genta RM, Rugge M. Gastric precancerous lesions: heading for an international consensus. Gut 1999;45 Suppl 1:I5-8. [PMID: 10457028 DOI: 10.1136/gut.45.2008.i5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
182 Hamajima N, Tajima K, Tominaga S, Matsuura A, Kuwabara M, Okuma K. Tea polyphenol intake and changes in serum pepsinogen levels. Jpn J Cancer Res 1999;90:136-43. [PMID: 10189883 DOI: 10.1111/j.1349-7006.1999.tb00726.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
183 Ozasa K, Kurata JH, Higashi A, Hayashi K, Inokuchi H, Miki K, Tada M, Kawai K, Watanabe Y. Helicobacter pylori infection and atrophic gastritis: a nested case-control study in a rural town in Japan. Dig Dis Sci. 1999;44:253-256. [PMID: 10063908 DOI: 10.1023/a:1026633913154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
184 Richardson P, Hawkey CJ, Stack WA. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs. 1998;56:307-335. [PMID: 9777309 DOI: 10.2165/00003495-199856030-00002] [Cited by in Crossref: 164] [Cited by in F6Publishing: 157] [Article Influence: 7.1] [Reference Citation Analysis]
185 Zhang T, O'Keefe SJ, Winter T, Marks IN, Ogden J. Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans. Dig Dis Sci 1998;43:2764-70. [PMID: 9881512 DOI: 10.1023/a:1026680017329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
186 Werdmuller BF, V/der Putten AB, Veenendaal RA, Lamers CB, Loffeld RJ. Can screening for IgG antibodies against Helicobacter pylori be used in clinical practice? Omit endoscopy in seropositive or seronegative patients? Dig Dis Sci 1998;43:2296-300. [PMID: 9836890 DOI: 10.1023/a:1026683026028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
187 el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-33. [PMID: 9863476 DOI: 10.1136/gut.43.3.327] [Cited by in Crossref: 251] [Cited by in F6Publishing: 232] [Article Influence: 10.5] [Reference Citation Analysis]
188 Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Malfertheiner P, Stolte M, Bayerdörffer E. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer. 1998;78:263-266. [PMID: 9683304 DOI: 10.1038/bjc.1998.475] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 2.5] [Reference Citation Analysis]
189 Dev AT, Lambert JR. 6. Diseases associated with Helicobacter pylori. Medical Journal of Australia 1998;169:220-5. [DOI: 10.5694/j.1326-5377.1998.tb140228.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
190 Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE. CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol. 1998;51:225-228. [PMID: 9659265 DOI: 10.1136/jcp.51.3.225] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 2.8] [Reference Citation Analysis]
191 Hackelsberger A, Günther T, Schultze V, Manes G, Dominguez-Muñoz JE, Roessner A, Malfertheiner P. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21. [PMID: 9771400 DOI: 10.1136/gut.43.1.17] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 4.2] [Reference Citation Analysis]
192 Forman D. Helicobacter pylori: the gastric cancer problem. Gut 1998;43 Suppl 1:S33-4. [PMID: 9764037 DOI: 10.1136/gut.43.2008.s33] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
193 Anti M, Armuzzi A, Gasbarrini A, Gasbarrini G. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut 1998;43 Suppl 1:S27-32. [PMID: 9764036 DOI: 10.1136/gut.43.2008.s27] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
194 Genta RM. Acid suppression and gastric atrophy: sifting fact from fiction. Gut 1998;43 Suppl 1:S35-8. [PMID: 9764038 DOI: 10.1136/gut.43.2008.s35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
195 Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol 1998;93:394-400. [PMID: 9517647 DOI: 10.1111/j.1572-0241.1998.00394.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
196 Berstad AE, Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 1998;42:522-9. [PMID: 9616315 DOI: 10.1136/gut.42.4.522] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
197 Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy. Drugs Aging 1998;12:277-92. [PMID: 9571392 DOI: 10.2165/00002512-199812040-00003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
198 Hamajima N, Inoue M, Tajima K, Tominaga S, Matsuura A, Kobayashi S, Ariyoshi Y. Lifestyle and anti-Helicobacter pylori immunoglobulin G antibody among outpatients. Jpn J Cancer Res 1997;88:1038-43. [PMID: 9439678 DOI: 10.1111/j.1349-7006.1997.tb00327.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
199 Karvar S, Karch H, Frosch M, Burghardt W, Gross U. Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. J Clin Microbiol 1997;35:3058-61. [PMID: 9399494 DOI: 10.1128/jcm.35.12.3058-3061.1997] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
200 Trevisani L, Sartori S, Ruina M, Caselli M, Abbasciano V, Grandi E, Forini E. Touch cytology. A reliable and cost-effective method for diagnosis of Helicobacter pylori infection. Dig Dis Sci 1997;42:2299-303. [PMID: 9398809 DOI: 10.1023/a:1018874919571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
201 Lindsay JA. Chronic sequelae of foodborne disease. Emerg Infect Dis 1997;3:443-52. [PMID: 9366595 DOI: 10.3201/eid0304.970405] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
202 Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997;41:740-7. [PMID: 9462205 DOI: 10.1136/gut.41.6.740] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.1] [Reference Citation Analysis]
203 Faller G, Steininger H, Kränzlein J, Maul H, Kerkau T, Hensen J, Hahn EG, Kirchner T. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997;41:619-23. [PMID: 9414967 DOI: 10.1136/gut.41.5.619] [Cited by in Crossref: 97] [Cited by in F6Publishing: 75] [Article Influence: 3.9] [Reference Citation Analysis]
204 Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 1997;41:277-80. [PMID: 9378377 DOI: 10.1136/gut.41.3.277] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 3.4] [Reference Citation Analysis]
205 Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci. 1997;42:103-105. [PMID: 9009123 DOI: 10.1023/a:1018841222856] [Cited by in Crossref: 111] [Cited by in F6Publishing: 126] [Article Influence: 4.4] [Reference Citation Analysis]
206 Patchett SE, Katelaris PH, Zhang ZW, Alstead EM, Domizio P, Farthing MJ. Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection. Gut 1996;39:807-10. [PMID: 9038661 DOI: 10.1136/gut.39.6.807] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
207 Su YC, Wang WM, Chen LT, Chiang W, Chen CY, Lu SN, Jan CM. High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan. Dig Dis Sci 1996;41:1571-6. [PMID: 8769281 DOI: 10.1007/BF02087902] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
208 Faller G, Steininger H, Eck M, Hensen J, Hann EG, Kirchner T. Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch. 1996;427:483-486. [PMID: 8624577 DOI: 10.1007/bf00199508] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 2.5] [Reference Citation Analysis]